Eyal Lebel, Ahmed Abdulgawad, Stefania Bramanti, Gonzalo Garate, Phoebe Joy Ho, Mikko Keränen, Yaël Cohen, Maja Vase, Amit Khot, Ida Bruun Kristensen, Richard LeBlanc, Cindy Lee, Wojciech Legiec, Hila Magen, María-Victoria Mateos, Danielle Oh, Ludek Pour, Natalia Schutz, Alexandros Spyridonidis, Katja Weisel, Jan Zaucha, Sarah Larson, Asya Varshasvsky, Kimberly Grazioli, Debashree Basudhar, Hongxiang Hu, Ya Meng, Lamis Eldjerou, Susan Bal, Simon Harrison, Rakesh Popat, Marc Raab, Paula Rodriguez-Otero. "Trial in progress: QUINTESSENTIAL-2—a phase 3 study of arlocabtagene autoleucel versus standard of care in adult patients with relapsed and refractory multiple myeloma (RRMM) exposed to lenalidomide." Blood, 2025. doi:10.1182/blood-2025-2302